Screener
Asset Entities ASST Medical Device — Other Operating Income
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Asset Entities in its filing.
Tagged under the XBRL concept us-gaap:OtherOperatingIncomeExpenseNet.
The source filing: Asset Entities’s 10-Q, filed August 10, 2026.
- Filed
- Aug 10, 2026, 7:01 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-054985
| Line item | Successor / Three Months Ended June 30, 2026 | Predecessor / Three Months Ended June 30, 2025 |
|---|---|---|
| Net unrealized loss on digital assets, at fair value | (228,031) | — |
| Net unrealized loss on investments in preferred equity, at fair value | (5,962) | — |
| Other investment loss | (2,801) | — |
| Total investment losses | (236,794) | — |
| Net operating loss | (258,249) | (3,690) |
| Other income/(expense): | ||
| Other income | 955 | 252 |
| Interest expense on long-term notes payable, at fair value | (40) | — |
Item 1. Consolidated Financial Statements
FAQ
- What is Asset Entities's medical device — other operating income?
- Asset Entities (ASST) reported medical device — other operating income of $0 in Q2 2026.
- What does medical device — other operating income mean?
- This represents miscellaneous income or expenses that are incidental to the core operations of the business segment. It captures non-recurring or secondary financial items that do not fit into standard operating expense categories. Monitoring this helps isolate core business performance from peripheral financial events.
Ask your AI about Asset Entities's medical device — other operating income.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude